growing need for 2nd and 3rd-line therapies in

Growing need for second- and third-line therapies boosts
commercial opportunity


Introduction
Faced with limited growth opportunities in western markets, HIV drug developers are looking to expand into emerging markets,
marked by a higher disease burden and greater medical unmet need. Efforts to improve treatment coverage coupled with a growing
affluent middle class and private sector have turned countries like Brazil, Russia or India into a promising commercial opportunity.


http://www.reportlinker.com/p0204521/Stakeholder-Opinions-HIV-in-Emerging-Markets-Brazil-Russia-India-Growing-need-for-second-and-third-line-therapies-boosts-commercial-opportunity.pdf

yeah, makes the naive twisted slant of no market look a little stupid...